As previously described, the patients with acute myeloid leukemia (AML) exhibit higher levels of plasma exosomes with a specific phenotype containing transforming growth factor beta 1 (TGFβ-1), which has a suppressive effect in the cytotoxic activity of NK cells [150]. This evidence concerns the gene TGFB1 and acute myeloid leukemia.